SecProbe.io

CORRESP
1
filename1.htm

June 19, 2014

Via EDGAR Transmission

  United States Securities and Exchange Commission

  Division of Corporate Finance

  Washington, D.C. 20549

  Attn: Mr. Jay Ingram, Legal Branch Chief

    Re:
    Ekso Bionics Holdings, Inc.

    Registration Statement on Form S-1 (File No. 333-195783)

    Request
    for Acceleration

Ladies and Gentlemen:

Ekso Bionics Holdings, Inc., hereby requests
that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement under
Rule 461 of the Securities Act of 1933, as amended, and declare the Registration Statement effective at 12:00 noon, Eastern Daylight
Time, on Friday, June 20, 2014, or as soon thereafter as is practicable.

In making this request, the Company acknowledges
that:

 · Should the Commission or the staff of
the Commission, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from
taking any action with respect to the filing;

 · The action of the Commission or the staff,
acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the filing; and

 · The Company may not assert the declaration
of effectiveness as a defense in any proceedings initiated by the Commission or any person under the federal securities laws of
the United States.

Very truly yours,

Ekso Bionics Holdings, Inc.

    By:
       /s/ Max Scheder-Bieschin

    Name:  Max Scheder-Bieschin

    Title:  Chief Financial Officer

    cc:
    Kamyar Daneshvar, Staff Attorney

    Securities and Exchange Commission

{00155562.1
/ 1034-001}